Skip to main content

峆一药业 — Investor Relations & Filings

Ticker · 920478 Beijing Stock Exchange Manufacturing
Filings indexed 360 across all filing types
Latest filing 2026-04-15 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920478

About 峆一药业

Anhui Heyi Pharmaceutical Co., Ltd. specializes in the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company focuses on providing high-quality chemical products for various therapeutic areas, including cardiovascular, central nervous system, and anti-infective treatments. With a strong emphasis on technological innovation and quality control, it operates advanced manufacturing facilities that adhere to international standards. Its product portfolio includes key intermediates for widely used medications, supporting both domestic and global pharmaceutical supply chains. The company leverages its expertise in complex chemical synthesis to offer customized solutions and reliable supply to its partners in the life sciences sector.

Recent filings

Filing Released Lang Actions
2025年度独立董事述职报告(杨模荣)
Regulatory Filings
2026-04-15 Chinese
2025年年度报告摘要
Regulatory Filings
2026-04-15 Chinese
2025年年度报告
Regulatory Filings
2026-04-15 Chinese
国元证券股份有限公司关于安徽峆一药业股份有限公司2025年度持续督导跟踪报告
Regulatory Filings
2026-04-15 Chinese
审计报告
Regulatory Filings
2026-04-15 Chinese
关于公司及子公司拟向银行申请综合授信额度的公告
Regulatory Filings
2026-04-15 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.